BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3362953)

  • 1. Nicotine and arecoline as discriminative stimuli: involvement of a non-cholinergic mechanism for nicotine.
    Meltzer LT; Rosecrans JA
    Pharmacol Biochem Behav; 1988 Mar; 29(3):587-93. PubMed ID: 3362953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.
    Meltzer LT; Rosecrans JA
    Psychopharmacology (Berl); 1981; 75(4):383-7. PubMed ID: 6803285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arecoline induced nicotinic and muscarinic stimulation of the superior cervical ganglion of cat.
    Tripathi ON
    Biomed Biochim Acta; 1983; 42(2-3):275-82. PubMed ID: 6882412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine.
    Meltzer LT; Rosecrans JA
    Pharmacol Biochem Behav; 1981 Jul; 15(1):21-6. PubMed ID: 7291225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic aspects of the discriminative stimulus effects of arecoline.
    Winger G
    Behav Pharmacol; 2021 Oct; 32(7):581-589. PubMed ID: 34417356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine-physostigmine combination does not substitute for nicotine.
    Schechter MD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central sites and mechanisms of action of nicotine.
    Rosecrans JA; Meltzer LT
    Neurosci Biobehav Rev; 1981; 5(4):497-501. PubMed ID: 7322455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead-induced changes in muscarinic cholinergic sensitivity.
    Cory-Slechta DA; Pokora MJ
    Neurotoxicology; 1995; 16(2):337-47. PubMed ID: 7566693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine as a discriminative stimulus: a neurobehavioral approach to studying central cholinergic mechanisms.
    Rosecrans JA
    J Subst Abuse; 1989; 1(3):287-300. PubMed ID: 2535609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine as a discriminative stimulus: a neurobiobehavioral approach to studying central cholinergic mechanisms.
    Rosecrans JA
    J Subst Abuse; 1989; 1(3):287-300. PubMed ID: 7580220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic drugs regulate passive avoidance performance via the amygdala.
    Riekkinen P; Riekkinen M; Sirviö J
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the discriminative stimulus effects of physostigmine in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):241-6. PubMed ID: 2746500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW; Mogg A; Tafi E; Peacey E; Pullar IA; Szekeres P; Tricklebank M
    Psychopharmacology (Berl); 2007 Feb; 190(2):157-70. PubMed ID: 17115136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists.
    McGurk SR; Levin ED; Butcher LL
    Neuroscience; 1991; 44(1):137-47. PubMed ID: 1770993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the physostigmine stimulus in rats.
    Jung M; Perio A; Worms P; Soubrie P
    Psychopharmacology (Berl); 1988; 95(4):553-5. PubMed ID: 3145526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cholinergic drugs on delayed discrimination disruption by AF64A in rats].
    Miyata H; Hironaka N; Ando K
    Nihon Yakurigaku Zasshi; 1991 May; 97(5):259-66. PubMed ID: 1879804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the receptor mediating the nicotine discriminative stimulus.
    Romano C; Goldstein A; Jewell NP
    Psychopharmacology (Berl); 1981; 74(4):310-5. PubMed ID: 6794072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.
    Bevins RA; Wilkinson JL; Palmatier MI; Siebert HL; Wiltgen SM
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):470-81. PubMed ID: 16047193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.